Hochschulschrift
Role of the microtubulin-associated molecule tau in inflammatory-mediated axonal damage
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erscheinungsjahr an der Haupttitelstelle: 2006
Göttingen, Univ., Diss., 2007
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
- URN
-
urn:nbn:de:gbv:7-webdoc-1710-2
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Nerve ultrasound distinguishes non-inflammatory axonal polyneuropathy from inflammatory polyneuropathy with secondary axonal damage
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Effect of nitric oxide and inflammatory mediators on axonal transport
Effect of nitric oxide and inflammatory mediators on axonal transport
Assessment of axonal and neuronal damage in a model of excitotoxicity
CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis
AFG3L2 deficiency impairs axonal transport of mitochondria dependent on ROS and tau levels
Synaptophysin presents a reliable marker to detect axonal damage in animal models of multiple sclerosis
Molecular Characterization of E587 Antigen : an Axonal Recognition Molecule Expressed in the Goldfish Central Nervous System
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting
Nerve ultrasound distinguishes non-inflammatory axonal polyneuropathy from inflammatory polyneuropathy with secondary axonal damage
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Effect of nitric oxide and inflammatory mediators on axonal transport
Effect of nitric oxide and inflammatory mediators on axonal transport
Assessment of axonal and neuronal damage in a model of excitotoxicity
CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis
AFG3L2 deficiency impairs axonal transport of mitochondria dependent on ROS and tau levels
Synaptophysin presents a reliable marker to detect axonal damage in animal models of multiple sclerosis
Molecular Characterization of E587 Antigen : an Axonal Recognition Molecule Expressed in the Goldfish Central Nervous System
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting
Nerve ultrasound distinguishes non-inflammatory axonal polyneuropathy from inflammatory polyneuropathy with secondary axonal damage
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Effect of nitric oxide and inflammatory mediators on axonal transport
Effect of nitric oxide and inflammatory mediators on axonal transport
Assessment of axonal and neuronal damage in a model of excitotoxicity
CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitis
AFG3L2 deficiency impairs axonal transport of mitochondria dependent on ROS and tau levels
Synaptophysin presents a reliable marker to detect axonal damage in animal models of multiple sclerosis
Molecular Characterization of E587 Antigen : an Axonal Recognition Molecule Expressed in the Goldfish Central Nervous System
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS